New gel could speed healing for diabetics after tooth removal
NCT ID NCT07429812
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a gel made from chitosan and chlorhexidine on wound healing after lower molar extraction in diabetic patients. Forty adults with controlled diabetes will receive either the gel or standard care. The goal is to see if the gel reduces pain, swelling, and improves early healing.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- chitosan 0.2% chlorhexidine gel
- What this could lead to
- If it works, this gel could improve healing and reduce pain and swelling after tooth extraction in people with diabetes.
- What could go wrong
- This is a small, early-stage trial with only 40 participants. The gel may not significantly improve healing, and results may not apply to all diabetic patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults with controlled diabetes (HbA1c \<7 * Mandibular molar extraction indicated Exclusion Criteria: * Immunocompromised, allergyto Chitosan/CHX.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Tanta University
Al Kharj, 16272, Saudi Arabia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sickle cell clues to diabetes risk hidden in DNA
- Can mindfulness and yoga rewire diabetes habits?
- Can a vegan diet delivered online help people with type 2 diabetes?
- Can coconut oil and moringa rinses fight gum disease in diabetic kids?
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Eye scans as a window to the body: study probes retinal imaging across diseases